Julie-An Talano, MD
Medical College of Wisconsin · Medical College of Wisconsin/Children's Hospital of Wisconsin
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Julie-An Talano, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:51 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT04049383 · CAR-20/19-T Cells in Patients With Relapsed/Refractory B Cell ALLMedical College of Wisconsin · terminated · Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia With Failed Remission, Acute Lymphoblastic Leukemia Recurrent · principal investigator
- Ph2NCT02600208 · Peripheral Blood Stem Cell Transplantation for Hematologic Malignancies With Alpha Beta TCell and B Cell Depletion Using the CliniMACS DeviceJulie-An M. Talano · active not recruiting · Hematologic Malignancies · principal investigator
- Ph1NCT01535885 · Using Multi-virus Cytotoxic T-cells Following T-Cell Depleted Allogeneic HPCT for Prophylaxis Against EBV, ADV, and CMVMedical College of Wisconsin · completed · Epstein-Barr Virus Infections, Adenovirus, Cytomegalovirus Infections · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:51 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in childhood acute lymphoblastic leukemia.